knowledge -WSS

knowledge

author：focus 2025-08-12 08:30:36 - browse：2

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： It costs an awful lot of money to give away a kidney

WSS

Personalized medicine goes far beyond genetics

Pharma companies must ensure equitable access to obesity drugs

California wildfire smoke linked to 52,000 early deaths, study says

Biotech startup Celsius cuts 75% of staff ahead of first trial start

How to ethically and practically extend health care to all

'Null' research findings aren't empty of meaning. Let's publish them

Wikipedia

knowledge

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

'Null' research findings aren't empty of meaning. Let's publish them

ChatGPT in medicine: STAT answers readers' burning questions

The a glaring gap in research on serious mental illness and primary care

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How to ethically and practically extend health care to all

Supreme Court strikes down use of affirmative action

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biotech startup Celsius cuts 75% of staff ahead of first trial start

knowledge

Readers discuss the intersection of pregnancy and addiction

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

The system is set up to fail children with medical complexity

When waiting feels immoral: Empathy in the emergency department

'Essentially witchcraft:' A former naturopath takes on the field

When waiting feels immoral: Empathy in the emergency department

explore

leisure time

leisure time

Wikipedia